Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation

Human Gene Therapy

Volumn 22, Issue 7, 2011, Pages 829-841

  Borchers, Sylvia ^a   Provasi, Elena ^b   Silvani, Anna ^c   Radrizzani, Marina ^c   Benati, Claudia ^c   Dammann, Elke ^a   Krons, Annika ^d   Kontsendorn, Julia ^a   Schmidtke, Joerg ^a   Kuehnau, Wolfgang ^a   Von Neuhoff, Nils ^a   Stadler, Michael ^a   Ciceri, Fabio ^b   Bonini, Chiara ^b   Ganser, Arnold ^a   Hertenstein, Bernd ^a,d   Weissinger, Eva M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c MOLMED S P A   (Italy)

^d Mosaiques Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DNA MODIFICATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HLA SYSTEM; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE TRANSFUSION; LYMPHOCYTE TRANSFUSION; MALE; MYELOABLATIVE CONDITIONING; ONCOGENE; PROTEOMICS; RETRANSPLANTATION; RETROVIRUS; SEPSIS; SIBLING; T LYMPHOCYTE; VIRUS REPLICATION;

ADULT; CHIMERISM; FEMALE; FUSION PROTEINS, BCR-ABL; GENETIC VECTORS; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE TRANSFUSION; MALE; MIDDLE AGED; PROTEOMICS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REMISSION INDUCTION; RETROVIRIDAE; THYMIDINE KINASE; TISSUE DONORS; TRANSDUCTION, GENETIC; TRANSGENES;

HERPES;

EID: 79960370424     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.162     Document Type: Article

References (42)

1. Bahceci, E., Epperson, D., Douek, D.C., et al. (2003). Early re-constitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. Br. J. Haematol. 122, 934-943. (Pubitemid 37174614)
2. Barrett, A.J., Mavroudis, D., Tisdale, J., et al. (1998). T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant. 21, 543-551. (Pubitemid 28138252)
3. Bondanza, A., Valtolina, V., Magnani, Z., et al. (2006). Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107, 1828-1836. (Pubitemid 43289360)
4. Bonini, C., Ciceri, F., Marktel, S., et al. (1998). Suicide-gene- transduced T-cells for the regulation of the graft-versus-leukemia effect. Vox Sanguinis 74(Suppl. 2), 341-343. (Pubitemid 28379803)
5. \+-selected peripheral blood cells. Exp. Hematol. 26, 415-420. (Pubitemid 28198739)
6. Ciceri, F., Bonini, C., Marktel, S., et al. (2007). Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. Blood 109, 4698-4707. (Pubitemid 46827761)
7. Ciceri, F., Bonini, C., Stanghellini, M.T.L., et al. (2009). Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): A non-randomised phase I-II study. Lancet Oncol. 10, 489-500.
8. Contassot, E., Ferrand, C., Angonin, R., et al. (2000). Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting. Transplantation 69, 503-508. (Pubitemid 30129580)
9. Epperson, D.E., Margolis, D.A., McOlash, L., et al. (2001). In vitro T-cell receptor Vb repertoire analysis may identify which T-cell Vb families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation. Br. J. Haematol. 114, 57-62. (Pubitemid 32702633)
10. Ferrand, C., Robinet, E., Contassot, E., et al. (2000). Retrovirus-mediated gene transfer in primary T lymphocytes: Influence of the transduction/selection process and of ex vivo expansion on the T cell receptor b chain hypervariable region repertoire. Hum. Gene Ther. 11, 1151-1164. (Pubitemid 30331581)
11. Garin, M.I., Garrett, E., Tiberghien, P., et al. (2001). Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 97, 122-129. (Pubitemid 32061251)
12. Georges, G.E., Storb, R., Thompson, J.D., et al. (2000). Adoptive immunotherapy in canine mixed chimeras after non-myeloablative hematopoietic cell transplantation. Blood 95, 3262-3269. (Pubitemid 30321183)
13. Gratwohl, A., Brand, R., Apperley, J., et al. (2002). Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 100, 3877-3886. (Pubitemid 35396852)
14. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419. (Pubitemid 37296260)
15. Hertenstein, B., Hampl, W., Bunjes, D., et al. (1995). In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant. 15, 387-393.
16. Horowitz, M.M., Gale, R.P., Sondel, P.M., et al. (1990). Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562. (Pubitemid 20069191)
17. Kaiser, T., Kamal, H., Rank, A., et al. (2004a). Proteomics applied to the clinical follow-up of patients after allogeneic hemato-poietic stem cell transplantation. Blood 104, 340-349. (Pubitemid 38900013)
18. Kaiser, T., Wittke, S., Just, I., et al. (2004b). Capillary electro-phoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophoresis 25, 2044-2055. (Pubitemid 39136325)
19. Kolb, H.J., Schattenberg, A., Goldman, J.M., et al. (1995). Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86, 2041-2050.
20. Kolb, H.J., Schmid, C., Barrett, A.J., et al. (2004). Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103, 767-776. (Pubitemid 38129531)
21. Kornblau, S.M., Stiouf, I., Snell, V., et al. (2001). Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes. Cancer Res. 61, 3355-3360. (Pubitemid 32695025)
22. Li, Z., Dullmann, J., Schiedlmeier, B., et al. (2002) Murine leukemia induced by retroviral gene marking. Science 296, 497. (Pubitemid 34408663)
23. Markowitz, D., Goff, S., and Bank, A. (1988). Construction of a safe and efficient retrovirus packaging cell line. Adv. Exp. Med. Biol. 241, 35-40.
24. Markowitz, D.G., Goff, S.P., and Bank, A. (1988). Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments. Trans. Assoc. Am. Physicians 101, 212-218.
25. Marktel, S., Magnani, Z., Ciceri, F., et al. (2003). Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101, 1290-1298. (Pubitemid 36182498)
26. Massenkeil, G., Nagy, M., Le Coutre, P., et al. (2004). Non-myeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD. Hematol. J. 5, 395-402. (Pubitemid 39359275)
27. Mavilio, F., Ferrari, G., Rossini, S., et al. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997. (Pubitemid 24107926)
28. Naumov, V.Z., Saroiants, L.V., and Balybin, E.S. (1995). [Effects of endogenous cortisol on the function of nonspecific T-suppressors and quantitative characteristics of main subpop-ulations of circulating T-lymphocytes in leprosy]. Problemy Tuberkuleza 2, 49-51.
29. Rodriguez-Luaces, M., Ferra, C., Martin-Henao, G., et al. (2004). Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back. Eur. J. Haematol. 73, 162-168. (Pubitemid 39062238)
30. Sauce, D., Bodinier, M., Garin, M., et al. (2002a). Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 99, 1165-1173. (Pubitemid 37258302)
31. Sauce, D., Tonnelier, N., Duperrier, A., et al. (2002b). Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J. Hemat-other. Stem Cell Res. 11, 929-940. (Pubitemid 36139774)
32. Sauce, D., Mercier, P., Battini, J.L., et al. (2004). Preferential retroviral-mediated transduction of EBV-and CMV-specific T cells after polyclonal T-cell activation. Gene Ther. 11, 1019-1022. (Pubitemid 38923626)
33. Theodorescu, D., Wittke, S., Ross, M.M., et al. (2006). Discovery and validation of new protein biomarkers for urothelial cancer: A prospective analysis. Lancet Oncol. 7, 230-240. (Pubitemid 43286453)
34. Tiberghien, P. (1994). Use of suicide genes in gene therapy. J. Leukoc. Biol. 56, 203-209. (Pubitemid 24270503)
35. Tiberghien, P., Ferrand, C., Lioure, B., et al. (2001). Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 97, 63-72. (Pubitemid 32061243)
36. Traversari, C., Marktel, S., Magnani, Z., et al. (2007). The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. Blood 109, 4708-4715. (Pubitemid 46827762)
37. van Dongen, J.J., Macintyre, E.A., Gabert, J.A., et al. (1999). Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease: Report of the BIOMED-1 Concerted Action Investigation of minimal residual disease in acute leukemia. Leukemia 13, 1901-1928.
38. Verzeletti, S., Bonini, C., Marktel, S., et al. (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors. Hum. Gene Ther. 9, 2243-2251. (Pubitemid 28498010)
39. Weissinger, E.M., Franz, M., Voss, C., et al. (2000). Expression of HSV-TK suicide gene in primary T lymphocytes: The dog as a preclinical model. Cytokines Cell. Mol. Ther. 6, 25-33. (Pubitemid 30664321)
40. Weissinger, E.M., Wittke, S., Kaiser, T., et al. (2004). Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 65, 2426-2434. (Pubitemid 38670029)
41. Weissinger, E.M., Schiffer, E., Hertenstein, B., et al. (2007). Pro-teomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 109, 5511-5519. (Pubitemid 46890577)
42. Wittke, S., Fliser, D., Haubitz, M., et al. (2003). Determination of peptides and proteins in human urine with capillary electro-phoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J. Chromatogr. A 1013, 173-181. (Pubitemid 37297584)